Top

Published in:

01-05-2019 | Allergic Contact Dermatitis | Review Article

Contact Dermatitis in the Elderly: Predisposing Factors, Diagnosis, and Management

Authors: Ana Luiza Lima, Vanessa Timmermann, Tanja Illing, Peter Elsner

Published in: Drugs & Aging | Issue 5/2019

Abstract

Increased aging of the general population is a well-known fact with serious effects on health systems worldwide. Skin aging involves various immunological and structural changes that increase the risk of numerous skin diseases such as contact dermatitis. Contact dermatitis is characterized by an inflammation of the skin caused by an interaction between the skin and external agents and is divided into irritant and allergic contact dermatitis. Irritant contact dermatitis occurs on skin areas directly exposed to irritant substances, which results in a stream of pro-inflammatory cytokines mediating the skin injury. Asteatotic and perineal irritant contact dermatitis are the most important subtypes of irritant contact dermatitis in the elderly. Allergic contact dermatitis is a T cell-mediated inflammatory reaction and requires a prior sensitization. The most common allergens responsible for allergic contact dermatitis in the elderly are fragrance mix, nickel, and balsam of Peru. Elderly patients with stasis dermatitis, chronic wounds, and chronic venous insufficiency have an increased prevalence of sensitization due to the frequent exposure to topical treatments. In this review, the most common types of contact dermatitis in the elderly are enumerated in order to assist dermatologists and other physicians to identify contact dermatitis in this distinct group of the population.

United Nations DoEaSA, Population Division (2017) world population prospects: the 2017 revision, key findings and advance tables. https://esa.un.org/unpd/wpp/Publications/Files/WPP2017_KeyFindings.pdf2017. Accessed 1 Apr 2018

Caruso C, Buffa S, Candore G, Colonna-Romano G, Dunn-Walters D, Kipling D, et al. Mechanisms of immunosenescence. Immun Ageing. 2009;6:10. https://doi.org/10.1186/1742-4933-6-10.CrossRefPubMedPubMedCentral

Wiegand C, Raschke C, Elsner P. Skin aging: a brief summary of characteristic changes. Textbook of aging skin. Berlin/Heidelberg: Springer-Verlag; 2015.

Lukacs J, Elsner P. Irritant contact dermatitis. Textbook of aging skin. Berlin/Heidelberg: Springer-Verlag; 2015.

Fulop T, Dupuis G, Baehl S, Le Page A, Bourgade K, Frost E, et al. From inflamm-aging to immune-paralysis: a slippery slope during aging for immune-adaptation. Biogerontology. 2016;17(1):147–57. https://doi.org/10.1007/s10522-015-9615-7.CrossRefPubMed

Solana R, Tarazona R, Gayoso I, Lesur O, Dupuis G, Fulop T. Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans. Semin Immunol. 2012;24(5):331–41. https://doi.org/10.1016/j.smim.2012.04.008.CrossRefPubMed

Wenisch C, Patruta S, Daxbock F, Krause R, Horl W. Effect of age on human neutrophil function. J Leukoc Biol. 2000;67(1):40–5.CrossRefPubMed

Denkinger MD, Leins H, Schirmbeck R, Florian MC, Geiger H. HSC Aging and senescent immune remodeling. Trends Immunol. 2015;36(12):815–24. https://doi.org/10.1016/j.it.2015.10.008.CrossRefPubMedPubMedCentral

Listi F, Candore G, Modica MA, Russo M, Di Lorenzo G, Esposito-Pellitteri M, et al. A study of serum immunoglobulin levels in elderly persons that provides new insights into B cell immunosenescence. Ann N Y Acad Sci. 2006;1089:487–95. https://doi.org/10.1196/annals.1386.013.CrossRefPubMed

10.

Minciullo PL, Catalano A, Mandraffino G, Casciaro M, Crucitti A, Maltese G, et al. Inflammaging and anti-inflammaging: the role of cytokines in extreme longevity. Arch Immunol Ther Exp (Warsz). 2016;64(2):111–26. https://doi.org/10.1007/s00005-015-0377-3.CrossRef

11.

Di Lorenzo G, Di Bona D, Belluzzo F, Macchia L. Immunological and non-immunological mechanisms of allergic diseases in the elderly: biological and clinical characteristics. Immun Ageing. 2017;14:23. https://doi.org/10.1186/s12979-017-0105-4.CrossRefPubMedPubMedCentral

12.

Farage MA, Miller KW, Elsner P, Maibach HI. Structural characteristics of the aging skin: a review. Cutan Ocul Toxicol. 2007;26(4):343–57. https://doi.org/10.1080/15569520701622951.CrossRefPubMed

13.

Kosmadaki MG, Gilchrest BA. The role of telomeres in skin aging/photoaging. Micron. 2004;35(3):155–9. https://doi.org/10.1016/j.micron.2003.11.002.CrossRefPubMed

14.

Ning MS, Andl T. Control by a hair’s breadth: the role of microRNAs in the skin. Cell Mol Life Sci. 2013;70(7):1149–69. https://doi.org/10.1007/s00018-012-1117-z.CrossRefPubMed

15.

Kottner J, Lichterfeld A, Blume-Peytavi U. Maintaining skin integrity in the aged: a systematic review. Br J Dermatol. 2013;169(3):528–42. https://doi.org/10.1111/bjd.12469.CrossRefPubMed

16.

Thune P, Nilsen T, Hanstad IK, Gustavsen T, Lovig Dahl H. The water barrier function of the skin in relation to the water content of stratum corneum, pH and skin lipids. The effect of alkaline soap and syndet on dry skin in elderly, non-atopic patients. Acta Derm Venereol. 1988;68(4):277–83.

17.

Elsner P, Wilhelm D, Maibach HI. Sodium lauryl sulfate-induced irritant contact dermatitis in vulvar and forearm skin of premenopausal and postmenopausal women. J Am Acad Dermatol. 1990;23(4 Pt 1):648–52.CrossRefPubMed

18.

Harvell JD, Maibach HI. Percutaneous absorption and inflammation in aged skin: a review. J Am Acad Dermatol. 1994;31(6):1015–21.CrossRefPubMed

19.

Choi EH, Man MQ, Xu P, Xin S, Liu Z, Crumrine DA, et al. Stratum corneum acidification is impaired in moderately aged human and murine skin. J Invest Dermatol. 2007;127(12):2847–56. https://doi.org/10.1038/sj.jid.5700913.CrossRefPubMed

20.

Fenske NA, Lober CW. Structural and functional changes of normal aging skin. J Am Acad Dermatol. 1986;15(4 Pt 1):571–85.CrossRefPubMed

21.

Yaar M, Gilchrest BA. Skin aging: postulated mechanisms and consequent changes in structure and function. Clin Geriatr Med. 2001;17(4):617–30 (v).

22.

Sudel KM, Venzke K, Mielke H, Breitenbach U, Mundt C, Jaspers S, et al. Novel aspects of intrinsic and extrinsic aging of human skin: beneficial effects of soy extract. Photochem Photobiol. 2005;81(3):581–7. https://doi.org/10.1562/2004-06-16-RA-202.CrossRefPubMed

23.

Farage MA, Miller KW, Elsner P, Maibach HI. Characteristics of the aging skin. Adv Wound Care (New Rochelle). 2013;2(1):5–10. https://doi.org/10.1089/wound.2011.0356.CrossRefPubMedPubMedCentral

24.

Audisio RA, Ramesh H, Longo WE, Zbar AP, Pope D. Preoperative assessment of surgical risk in oncogeriatric patients. Oncologist. 2005;10(4):262–8. https://doi.org/10.1634/theoncologist.10-4-262.CrossRefPubMed

25.

Menon G, Ghadially R. Morphology of lipid alterations in the epidermis: a review. Microsc Res Tech. 1997;37(3):180–92. https://doi.org/10.1002/(SICI)1097-0029(19970501)37:3%3c180:AID-JEMT3%3e3.0.CO;2-S.CrossRefPubMed

26.

Saint-Mezard P, Krasteva M, Chavagnac C, Bosset S, Akiba H, Kehren J, et al. Afferent and efferent phases of allergic contact dermatitis (ACD) can be induced after a single skin contact with haptens: evidence using a mouse model of primary ACD. J Invest Dermatol. 2003;120(4):641–7. https://doi.org/10.1046/j.1523-1747.2003.12093.x.CrossRefPubMed

27.

Leonard A, Guttman-Yassky E. The unique molecular signatures of contact dermatitis and implications for treatment. Clin Rev Allergy Immunol. 2018. https://doi.org/10.1007/s12016-018-8685-0.

28.

Gittler JK, Krueger JG, Guttman-Yassky E. Atopic dermatitis results in intrinsic barrier and immune abnormalities: implications for contact dermatitis. J Allergy Clin Immunol. 2013;131(2):300–13. https://doi.org/10.1016/j.jaci.2012.06.048.CrossRefPubMed

29.

Simon M, Bernard D, Minondo AM, Camus C, Fiat F, Corcuff P, et al. Persistence of both peripheral and non-peripheral corneodesmosomes in the upper stratum corneum of winter xerosis skin versus only peripheral in normal skin. J Invest Dermatol. 2001;116(1):23–30. https://doi.org/10.1046/j.1523-1747.2001.00208.x.CrossRefPubMed

30.

Loffler H, Effendy I, Happle R. Irritant contact dermatitis. Hautarzt. 2000;51(3):203–15.CrossRefPubMed

31.

Beele H, Smet S, Van Damme N, Beeckman D. Incontinence-associated dermatitis: pathogenesis, contributing factors, prevention and management options. Drugs Aging. 2018;35(1):1–10. https://doi.org/10.1007/s40266-017-0507-1.CrossRefPubMed

32.

Fluhr JW, Dickel H, Kuss O, Weyher I, Diepgen TL, Berardesca E. Impact of anatomical location on barrier recovery, surface pH and stratum corneum hydration after acute barrier disruption. Br J Dermatol. 2002;146(5):770–6.CrossRefPubMed

33.

Adam R. Skin care of the diaper area. Pediatr Dermatol. 2008;25(4):427–33. https://doi.org/10.1111/j.1525-1470.2008.00725.x.CrossRefPubMed

34.

Mugita Y, Minematsu T, Huang L, Nakagami G, Kishi C, Ichikawa Y, et al. Histopathology of incontinence-associated skin lesions: inner tissue damage due to invasion of proteolytic enzymes and bacteria in macerated rat skin. PLoS One. 2015;10(9):e0138117. https://doi.org/10.1371/journal.pone.0138117.CrossRefPubMedPubMedCentral

35.

Campbell JL, Coyer FM, Mudge AM, Robertson IM, Osborne SR. Candida albicans colonisation, continence status and incontinence-associated dermatitis in the acute care setting: a pilot study. Int Wound J. 2017;14(3):488–95. https://doi.org/10.1111/iwj.12630.CrossRefPubMed

36.

Wilhelm KP, Maibach HI. Factors predisposing to cutaneous irritation. Dermatol Clin. 1990;8(1):17–22.CrossRefPubMed

37.

Slodownik D, Lee A, Nixon R. Irritant contact dermatitis: a review. Australas J Dermatol. 2008;49(1):1–9 (quiz 10-1). https://doi.org/10.1111/j.1440-0960.2007.00409.x.

38.

Krasteva M, Kehren J, Ducluzeau MT, Sayag M, Cacciapuoti M, Akiba H et al. Contact dermatitis I. Pathophysiology of contact sensitivity. Eur J Dermatol. 1999;9(1):65–77.

39.

Balato A, Balato N, Di Costanzo L, Ayala F. Contact sensitization in the elderly. Clin Dermatol. 2011;29(1):24–30. https://doi.org/10.1016/j.clindermatol.2010.07.003.CrossRefPubMed

40.

Buckley DA, Rycroft RJ, White IR, McFadden JP. The frequency of fragrance allergy in patch-tested patients increases with their age. Br J Dermatol. 2003;149(5):986–9.CrossRefPubMed

41.

Mahler V. Contact allergies in the elderly. Hautarzt. 2015;66(9):665–73. https://doi.org/10.1007/s00105-015-3668-z.CrossRefPubMed

42.

Wohrl S, Hemmer W, Focke M, Gotz M, Jarisch R. Patch testing in children, adults, and the elderly: influence of age and sex on sensitization patterns. Pediatr Dermatol. 2003;20(2):119–23.CrossRefPubMed

43.

Piaserico S, Larese F, Recchia GP, Corradin MT, Scardigli F, Gennaro F, et al. Allergic contact sensitivity in elderly patients. Aging Clin Exp Res. 2004;16(3):221–5.CrossRefPubMed

44.

Balato A, Balato N, Di Costanzo L, Ayala F. Contact sensitization of older patients in an academic department in Naples. Italy. Dermatitis. 2008;19(4):209–12.CrossRef

45.

Nanda A, Wasan A. Allergic contact dermatitis to balsam of Peru. Ann Allergy Asthma Immunol. 2016;117(2):208–9. https://doi.org/10.1016/j.anai.2016.06.012.CrossRefPubMed

46.

Wakelin SH, Smith H, White IR, Rycroft RJ, McFadden JP. A retrospective analysis of contact allergy to lanolin. Br J Dermatol. 2001;145(1):28–31.CrossRefPubMed

47.

Bordel-Gomez MT, Miranda-Romero A. Contact sensitization to Euxyl K-400. Actas Dermosifiliogr. 2009;100(3):201–4.CrossRefPubMed

48.

Tennvall GR, Andersson K, Bjellerup M, Hjelmgren J, Oien R. [Treatment of venous leg ulcers can be better and cheaper. Annual costs calculation based on an inquiry study]. Lakartidningen. 2004;101(17):1506–10, 12–3.

49.

Maddox D. Effects of venous leg ulceration on patients’ quality of life. Nurs Stand. 2012;26(38):42–9. https://doi.org/10.7748/ns2012.05.26.38.42.c9111.CrossRefPubMed

50.

Saap L, Fahim S, Arsenault E, Pratt M, Pierscianowski T, Falanga V, et al. Contact sensitivity in patients with leg ulcerations: a North American study. Arch Dermatol. 2004;140(10):1241–6. https://doi.org/10.1001/archderm.140.10.1241.CrossRefPubMed

51.

Machet L, Couhe C, Perrinaud A, Hoarau C, Lorette G, Vaillant L. A high prevalence of sensitization still persists in leg ulcer patients: a retrospective series of 106 patients tested between 2001 and 2002 and a meta-analysis of 1975–2003 data. Br J Dermatol. 2004;150(5):929–35. https://doi.org/10.1111/j.1365-2133.2004.05917.x.CrossRefPubMed

52.

Kulberg A, Schliemann S, Elsner P. Contact dermatitis as a systemic disease. Clin Dermatol. 2014;32(3):414–9. https://doi.org/10.1016/j.clindermatol.2013.11.008.CrossRefPubMed

53.

Veien NK. Systemic contact dermatitis. Int J Dermatol. 2011;50(12):1445–56. https://doi.org/10.1111/j.1365-4632.2011.05104.x.CrossRefPubMed

54.

Koch L, Aberer W. Allergic contact dermatitis of the scalp. Hautarzt. 2017;68(6):466–71. https://doi.org/10.1007/s00105-017-3975-7.CrossRefPubMed

55.

Cohen DE, Heidary N. Treatment of irritant and allergic contact dermatitis. Dermatol Ther. 2004;17(4):334–40. https://doi.org/10.1111/j.1396-0296.2004.04031.x.CrossRefPubMed

Title: Contact Dermatitis in the Elderly: Predisposing Factors, Diagnosis, and Management
Authors: Ana Luiza Lima
Vanessa Timmermann
Tanja Illing
Peter Elsner
Publication date: 01-05-2019
Publisher: Springer International Publishing
Keywords: Allergic Contact Dermatitis
Chronic Venous Insufficiency
Skin Aging
Chronic Venous Insufficiency
Published in: Drugs & Aging / Issue 5/2019
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI: https://doi.org/10.1007/s40266-019-00641-4

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2019

The FORTA (Fit fOR The Aged) List 2018: Third Version of a Validated Clinical Tool for Improved Drug Treatment in Older People

Potentially Inappropriate Prescribing and Related Hospital Admissions in Geriatric Patients: A Comparative Analysis between the STOPP and START Criteria Versions 1 and 2

Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer’s Disease: A Network Meta-Analysis

Use of Medicines that May Exacerbate Heart Failure in Older Adults: Therapeutic Complexity of Multimorbidity

Treatment Decisions for Metastatic Clear Cell Renal Cell Carcinoma in Older Patients: The Role of TKIs and Immune Checkpoint Inhibitors

Modification of Potentially Inappropriate Prescribing Following Fall-Related Hospitalizations in Older Adults

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials